September 27, 2019

SECURITIES AND EXCHANGE COMMISSION v. MYLAN N.V

Track this case

Case Number:

1:19-cv-02904

Court:

District Of Columbia

Nature of Suit:

Securities/Commodities

Judge:

Randolph D. Moss

Companies

Government Agencies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 27, 2019

    Mylan Inks $30M SEC Deal After Not Disclosing EpiPen Probe

    Mylan NV will pay the U.S. Securities and Exchange Commission $30 million to resolve allegations that it failed to warn investors about potential losses tied to an investigation into the drugmaker's EpiPen classification, according to filings in D.C. federal court Friday.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login